Acta paediatrica (Oslo, Norway : 1992) · 2025
Testing for Faecal Gluten Immunogenic Peptides: Is It Useful to Evaluate Adherence to Gluten-Free Diet?
СтатьяПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Cenni Sabrina, Casertano Marianna, D'Addio Elisabetta, Pacella Daniela, Tolone Carlo, Martinelli Massimo, Staiano Annamaria, Miele Erasmo, Strisciuglio Caterina
Аннотация
AIM: Determination of faecal gluten immunogenic peptides (f-GIP) has recently been proposed as new noninvasive method to detect gluten intake in celiac disease (CD). Our aim was to evaluate the use of f-GIP for the adherence to gluten-free diet (GFD) and to compare this new marker with traditional methods.
METHODS: We enrolled both newly diagnosed cases and children in follow-up with CD. Adherence to the GFD was assessed using the Biagi score, IgA anti-transglutaminase (tTG IgA) and f-GIP.
RESULTS: Seventy-one CD children, 40.8% new diagnosis and 59.2% in follow-up, were enrolled. Significant differences were found in the levels of faecal GIP between new diagnosis and follow up (median 185.7 ng/mL, IQR 67.8-318.8 ng/mL and 16.6 ng/mL, IQR 6.9-61 ng/mL respectively, p < 0.001). A significant direct correlation was found between faecal GIP and tTG IgA in the total cohort of enrolled patients (r = 0.5, p < 0.001). In the follow up group, 21.4% tested positive for GIP and, of these GIP + patients, 78% had a high Biagi score.
CONCLUSION: Our data shows that faecal GIP offers a precise assessment of even occasional exposure to gluten and suggests it might represent a less invasive instrument to check dietary adherence compared to traditional methods.
METHODS: We enrolled both newly diagnosed cases and children in follow-up with CD. Adherence to the GFD was assessed using the Biagi score, IgA anti-transglutaminase (tTG IgA) and f-GIP.
RESULTS: Seventy-one CD children, 40.8% new diagnosis and 59.2% in follow-up, were enrolled. Significant differences were found in the levels of faecal GIP between new diagnosis and follow up (median 185.7 ng/mL, IQR 67.8-318.8 ng/mL and 16.6 ng/mL, IQR 6.9-61 ng/mL respectively, p < 0.001). A significant direct correlation was found between faecal GIP and tTG IgA in the total cohort of enrolled patients (r = 0.5, p < 0.001). In the follow up group, 21.4% tested positive for GIP and, of these GIP + patients, 78% had a high Biagi score.
CONCLUSION: Our data shows that faecal GIP offers a precise assessment of even occasional exposure to gluten and suggests it might represent a less invasive instrument to check dietary adherence compared to traditional methods.